You are here: Industry Insights > Agilent

News List

Agilent continues to focus on strategic M&A, R&D investment to expand product portfolio expresspharma
March 15, 2021
Samir Vyas, Country Manager, Agilent India says India companies are now moving into the global biopharma market and gives his views on the role of policies like Make in India/Atmanirbhar Bharat, a more vigilant US FDA after the sartan episode and ...
Agilent to invest $150m for expansion of Frederick production facility in US pharmaceutical-business-review
August 20, 2020
Agilent Technologies has announced an investment of up to $150m to expand its production facility for nucleic acid-based therapeutics in the US.
CNMPA approves Agilent's PD-L1 Companion Diagnostic biospectrumasia
October 08, 2019
The assay is now approved as a companion diagnostic to identify patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors express PD-L1 (tumor proportion score [TPS] >1%) for first-line treatment with single-agent KEYTRU
Agilent Introduces Real-Time Cell Analyzer americanpharmaceuticalreview
August 16, 2019
Agilent introduced a multimode real-time cell analyzer combining non-invasive biosensor measurement with live cell imaging.
Agilent Companion Diagnostic Gains Expanded FDA Approval in Urothelial Carcinoma americanpharmaceuticalreview
August 23, 2018
Agilent announced that the U.S. Food and Drug Administration (FDA) has approved its Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma.
Agilent’s Keytruda PD-L1 assay expanded in Europe to cover first-line urothelial carcinoma fiercebiotech
August 09, 2018
Agilent Technologies’ PD-L1 assay received an expanded label in Europe to help guide the use of first-line Keytruda in urothelial carcinoma. Physicians can now use the assay to help identify patients who are ineligible for cisplatin treatment and may resp
Agilent Technologies Acquires ProZyme contractpharma
July 03, 2018
Agilent Technologies has entered into a definitive agreement to acquire privately-held ProZyme, a provider of glycan analysis reagents
Agilent opens new logistics hub in China biospectrumasia
July 02, 2018
The new centre will enable record on-time delivery of service parts and consumables to the customers, and is a model for the company’s future growth.
Agilent to acquire assets of Ultra Scientific biospectrumasia
June 01, 2018
The acquisition will help in significant expansion of Agilent's certified reference materials and chemical standards business
Agilent completes acquisition of Genohm biospectrumasia
May 16, 2018
This acquisition enhances Agilent’s current software portfolio

Previous page 1 2 3 Next page